Complejo Hospitalario de Especialidades Juan Ramón Jimenez   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Huelva Spain

Organization Overview

First Clinical Trial
2007
NCT00543127
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Complejo Hospitalario de Especialidades Juan Ramón Jimenez

Active Ingredients

Drugs in Phase 4 Trials (1)

roflumilast (daliresp) (1 trial)

Drugs in Phase 3 Trials (4)

anastrozole (arimidex) (1 trial)

fulvestrant (faslodex) (1 trial)

piperacillin (pipracil) (1 trial)

tazobactam (Zosyn) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Infections (Phase 3)

Lung Diseases, Obstructive (Phase 4)

Pseudomonas Infections (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5